Isogen Life Science is a biotechnology company based in The Netherlands, with a focus on providing instruments, reagents, and consumables for cell biology, molecular biology, and biochemistry. With more than 30 years of experience in the market, the company has established itself as a go-to provider for leading research institutes and biotechnology companies. Isogen Life Science's commitment to innovation is evident in its pursuit of new products that aim to advance life science research and diagnostics. The company's headquarters in De Meern, the Netherlands, and sales operatives in Netherlands, Belgium, Luxembourg, Spain, Portugal, and the UK reflect its international presence. Furthermore, Isogen Life Science boasts its own service organization qualified to perform IQ/OQ/PQ, demonstrating dedication to customer satisfaction. Given its long-standing presence and emphasis on innovation, Isogen Life Science presents an intriguing opportunity for venture capitalists looking to invest in the health care and biotechnology sectors. With a wide range of products catering to essential research needs, the company holds significant potential for growth and further market penetration. For potential investors seeking to explore what Isogen Life Science has to offer and how it can elevate research endeavors to the next level, reaching out to the company's experts via [email protected] or +31 30 6880771 is a promising avenue for collaboration.
There is no investment information
No recent news or press coverage available for Isogen Life Science.